You searched for lung cancer | Page 98 of 167

Advancing Tuberculosis Testing

Posted by Steve Halasey | May 5, 2017 | Disease States, Flu & Respiratory Infections, Molecular Diagnostics, Respiratory Disease, Tuberculosis |

Protecting sample stability ensures the utility of the latest generation of TB tests.

April 2017 Product Spotlight: Emerging Technologies, Part 2

Posted by Elaine Sanchez Wilson | Apr 26, 2017 | Biochemicals & Chemical Reagents, Cancer, Coagulation Testing, Hematology & Serology, Osteoporosis, Transfusion & Transplantation Tests |

This month’s issue features emerging technologies from such companies as Clinical Genomics, Hamilton Storage, and Symcel.

Owlstone Medical Opens High-Volume Breath Biopsy Lab

Posted by Elaine Sanchez Wilson | Apr 18, 2017 | Cancer |

Facilities will have access to high-throughput biomarker services for identification of novel breath biomarkers in disease diagnostics and precision medicine applications.

Multiplex cfDNA Reference Standard Set in Synthetic Plasma

Posted by Elaine Sanchez Wilson | Apr 11, 2017 | Cancer, Molecular Diagnostics, Quality Systems, Standards |

The new format directly addresses DNA extraction, one of the key sources of variability in cfDNA assays.

The Evolution of the PD-L1 Testing Market

Posted by Elaine Sanchez Wilson | Apr 4, 2017 | Cancer, Molecular Diagnostics |

The dynamic PD-L1 space is providing opportunities to undertake real-time market analysis and ultimately improve our understanding of novel biomarker adoption.

Search Results for: lung cancer

Advancing Tuberculosis Testing

April 2017 Product Spotlight: Emerging Technologies, Part 2

Owlstone Medical Opens High-Volume Breath Biopsy Lab

Multiplex cfDNA Reference Standard Set in Synthetic Plasma

The Evolution of the PD-L1 Testing Market

Recent Posts

Clinical Lab Products

Our Parent Company

Key Resources

Helpful Links